FTSE 100 pharma giants GSK and Astrazeneca may have escaped the worst of US President Donald Trump’s tariffs, according to a ...
1don MSN
Walmsley says GSK is “incredibly intentional” in how the company recruits and trains talent. The company’s management has ...
NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies ...
Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...
GSK Plc is pushing the UK government to give pharmaceutical companies more access to its public health data troves, to ...
On the FTSE 350, Watches of Switzerland is down 15%, while Vietnam focused investment trusts VinaCapital Vietnam Opportunity ...
Shares of GSK plc (LON:GSK – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, MarketBeat reports. One research ...
The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...
Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...
GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the ...
The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...
8d
GlobalData on MSNGSK and UK researchers plan to study Shingrix and dementia risk reduction linkThe study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results